Elimination of 15N-thymidine after oral administration in human infants is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: R01 HL151386
National Heart, Lung, and Blood Institute
Grant: R01HL155597
National Center for Advancing Translational Sciences
Grant: UL1 TR001857, KL2 TR001856, and/or TL1 TR001858
National Institutes of Health
Grant: T32HD071834
National Institutes of Health
Grant: 2T32HD071834-06A1
Research Training Program for Pediatric Subspecialty Fellows
National Institutes of Health
Grant: 3KL2TR001856-08S1
Institutional Career Development Core
National Institutes of Health
Grant: 5R01HL151386-03
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients
National Institutes of Health
Grant: 1R01HL155597-01A1
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot
National Institutes of Health
Grant: 3TL1TR001858-07S1
Administrative Supplement to NIH-funded TL1 Training Grants
National Institutes of Health
Grant: 3UL1TR001857-07S1
University of Pittsburgh Clinical and Translational Science Institute
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals